Literature DB >> 22679635

[Subjective assessment of voice quality after surgical or radiotherapeutic treatment of glottic laryngeal carcinoma stage T1].

H Christiansen1, R M W Rödel.   

Abstract

Entities:  

Year:  2012        PMID： 22679635

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

Review 1.  Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision.

Authors:  Seth M Cohen; C Gaelyn Garrett; William D Dupont; Robert H Ossoff; Mark S Courey
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-08       Impact factor: 1.547

2.  Voice-related quality of life after treatment of laryngeal cancer.

Authors:  Nobuhiko Oridate; Akihiro Homma; Seigo Suzuki; Yuji Nakamaru; Fumiyuki Suzuki; Hiromitsu Hatakeyama; Shigenari Taki; Tomohiro Sakashita; Noriko Nishizawa; Yasushi Furuta; Satoshi Fukuda
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

3.  Voice outcome in T1a midcord glottic carcinoma: laser surgery vs radiotherapy.

Authors:  Elisabeth V Sjögren; Maya A van Rossum; Ton P M Langeveld; Marika S Voerman; Vivienne A H van de Kamp; Mark O W Friebel; Ron Wolterbeek; Robert J Baatenburg de Jong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-09

4.  Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure.

Authors:  Ralph M W Rödel; Wolfgang Steiner; Roland M Müller; Martina Kron; Christoph Matthias
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

5.  Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index.

Authors:  Faustino Núñez Batalla; Maria Jesús Caminero Cueva; Blanca Señaris González; José Luis Llorente Pendás; Carmen Gorriz Gil; Aurora López Llames; Ramón Alonso Pantiga; Carlos Suárez Nieto
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-13       Impact factor: 2.503
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.